ES2157883T3 - PROCEDURE FOR THE BIOCHEMICAL OXIDATION OF STEROIDS AND CELLS TRANSFORMED BY GENETIC ENGINEERING FOR THIS PURPOSE. - Google Patents

PROCEDURE FOR THE BIOCHEMICAL OXIDATION OF STEROIDS AND CELLS TRANSFORMED BY GENETIC ENGINEERING FOR THIS PURPOSE.

Info

Publication number
ES2157883T3
ES2157883T3 ES89201173T ES89201173T ES2157883T3 ES 2157883 T3 ES2157883 T3 ES 2157883T3 ES 89201173 T ES89201173 T ES 89201173T ES 89201173 T ES89201173 T ES 89201173T ES 2157883 T3 ES2157883 T3 ES 2157883T3
Authority
ES
Spain
Prior art keywords
cells
genetic engineering
steroids
procedure
cassets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89201173T
Other languages
Spanish (es)
Inventor
Harmen Slijkhuis
Gerardus Cornelis Maria Selten
Erik Bastiaan Smaal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Application granted granted Critical
Publication of ES2157883T3 publication Critical patent/ES2157883T3/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0023—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16
    • C07J5/003—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes
    • C07J5/0038—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y106/00—Oxidoreductases acting on NADH or NADPH (1.6)
    • C12Y106/02—Oxidoreductases acting on NADH or NADPH (1.6) with a heme protein as acceptor (1.6.2)
    • C12Y106/02004—NADPH-hemoprotein reductase (1.6.2.4), i.e. NADP-cytochrome P450-reductase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/009—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by only one oxygen atom doubly bound
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0036—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on NADH or NADPH (1.6)
    • C12N9/0038—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on NADH or NADPH (1.6) with a heme protein as acceptor (1.6.2)
    • C12N9/0042—NADPH-cytochrome P450 reductase (1.6.2.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0095—Oxidoreductases (1.) acting on iron-sulfur proteins as donor (1.18)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
    • C12Y101/01053—3-Alpha (or 20-beta)-hydroxysteroid dehydrogenase (1.1.1.53)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/15—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen (1.14.15)
    • C12Y114/15004—Steroid 11-beta-monooxygenase (1.14.15.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/15—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen (1.14.15)
    • C12Y114/15006—Cholesterol monooxygenase (side-chain-cleaving) (1.14.15.6), i.e. cytochrome P450scc
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/99—Miscellaneous (1.14.99)
    • C12Y114/99009—Steroid 17-alpha-monooxygenase (1.14.99.9), i.e. cytochrome-P450-steroid-17-alpha-hydroxylase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y118/00—Oxidoreductases acting on iron-sulfur proteins as donors (1.18)
    • C12Y118/01—Oxidoreductases acting on iron-sulfur proteins as donors (1.18) with NAD+ or NADP+ as acceptor (1.18.1)
    • C12Y118/01002—Ferredoxin-NADP+ reductase (1.18.1.2)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

LA INVENCION SE REFIERE A CELULAS HUESPED PRODUCIDAS POR INGENIERIA GENETICA QUE CONTIENEN NUEVAS CASETTES DE EXPRESION, CAPACES DE LLEVAR A CABO OXIDACIONES BIOQUIMICAS DE ESTEROIDES. EN PARTICULAR LA OXIDACION SE LLEVA A CABO CON CELULAS EN LAS QUE SE HA INTRODUCIDO DNA QUE CODIFICA LA PROTEINA IMPLICADA EN LA TRANSFORMACION BIOLOGICA DE COLESTEROL EN HIDROCORTISONA. LAS CELULAS HUESPED ADECUADAS COMPRENDEN ESPECIES DE BACILLUS, SACCHAROMYCES O KLUYVEROMYCES. LAS NUEVAS CELULAS HUESPED SON ADECUADA PARA OXIDACIONES MICROBIOLOGICAS DE COLESTEROL, PREGNENOLONA, PROGESTERONA, 17 ALFA - HIDROXIPROGESTERONA Y CORTEXOLONA, QUE SON INTERMEDIOS EN LA CITADA TRANSFOMACION BIOLOGICA. LAS NUEVAS CASETTES DE EXPRESION SON TAMBIEN UTILES EN LA PRODUCCION DE UN SISTEMA MULTIGENICA PARA LA CONVERSION EN UNA ETAPA DE COLESTEROL EN HIDROCORTISONA.THE INVENTION REFERS TO CELLS GUEST PRODUCED BY GENETIC ENGINEERING THAT CONTAIN NEW EXPRESSION CASSETS, ABLE TO CARRY OUT STEROID BIOCHEMICAL OXIDATIONS. IN PARTICULAR OXIDATION IS CARRIED OUT WITH CELLS IN WHICH DNA HAS BEEN INTRODUCED THAT CODIFIES THE PROTEIN INVOLVED IN THE BIOLOGICAL TRANSFORMATION OF CHOLESTEROL IN HYDROCORTISONE. THE PROPER CELLS INCLUDE SPECIES OF BACILLUS, SACCHAROMYCES OR KLUYVEROMYCES. THE NEW GUESTS CELLS ARE SUITABLE FOR MICROBIOLOGICAL OXIDATIONS OF COLESTEROL, PREGNENOLONE, PROGESTERONE, 17 ALPHA - HYDROXIPROGESTERONE AND CORTEXOLONE, WHICH ARE INTERMEDIATE IN THE CITED BIOLOGICAL TRANSFOMATION. THE NEW EXPRESSION CASSETS ARE ALSO USEFUL IN THE PRODUCTION OF A MULTIGENIC SYSTEM FOR CONVERSION IN A CHOLESTEROL STAGE IN HYDROCORTISONE.

ES89201173T 1988-05-06 1989-05-08 PROCEDURE FOR THE BIOCHEMICAL OXIDATION OF STEROIDS AND CELLS TRANSFORMED BY GENETIC ENGINEERING FOR THIS PURPOSE. Expired - Lifetime ES2157883T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP88200904 1988-05-06
EP88202080 1988-09-23

Publications (1)

Publication Number Publication Date
ES2157883T3 true ES2157883T3 (en) 2001-09-01

Family

ID=26115083

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89201173T Expired - Lifetime ES2157883T3 (en) 1988-05-06 1989-05-08 PROCEDURE FOR THE BIOCHEMICAL OXIDATION OF STEROIDS AND CELLS TRANSFORMED BY GENETIC ENGINEERING FOR THIS PURPOSE.

Country Status (16)

Country Link
JP (2) JP2963711B2 (en)
KR (1) KR100256025B1 (en)
CN (1) CN1038667A (en)
AT (1) ATE201235T1 (en)
AU (1) AU635494B2 (en)
CA (1) CA1340616C (en)
DE (1) DE68929296T2 (en)
DK (1) DK175573B1 (en)
ES (1) ES2157883T3 (en)
FI (1) FI109605B (en)
HU (1) HU217411B (en)
IL (1) IL90207A (en)
NO (1) NO314267B1 (en)
NZ (1) NZ229032A (en)
PT (1) PT90484B (en)
WO (1) WO1989010963A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1042567A (en) * 1988-09-23 1990-05-30 吉斯特-布罗卡迪斯公司 Steroid multi-step oxidation method and genetically engineered cells used
DE69122016T2 (en) * 1990-09-26 1997-04-30 Sumitomo Chemical Co Mitochondrial P450
US5420027A (en) * 1991-01-10 1995-05-30 Board Of Regents, The University Of Texas System Methods and compositions for the expression of biologically active fusion proteins comprising a eukaryotic cytochrome P450 fused to a reductase in bacteria
US5240831A (en) * 1991-01-10 1993-08-31 Board Of Regents, The University Of Texas Methods and compositions for the expression of biologically active eukaryotic cytochrome p45os in bacteria
US9255256B2 (en) 1996-07-17 2016-02-09 Btg International Limited Expression of functional cytochorome P450 monooxygenase system in enterobacteria
GB9615032D0 (en) 1996-07-17 1996-09-04 Univ Dundee Enzyme system
FR2820145B1 (en) * 2001-01-31 2004-01-23 Aventis Pharma Sa YEAST STRAIN PRODUCING INDEPENDENT STEROIDS
CN102272304B (en) * 2009-01-07 2013-10-23 三菱化学株式会社 Enzyme protein for cutting sterol side chain and its application
US10308972B2 (en) 2013-06-17 2019-06-04 Sanofi Chimie Whole-cell system for cytochrome P450 monooxygenases biocatalysis
RU2677997C2 (en) * 2014-01-20 2019-01-22 Санофи Novel cytochrome p450 polypeptide with increased enzymatic activity
JP5800040B2 (en) * 2014-01-29 2015-10-28 三菱化学株式会社 Sterol side chain cleaving enzyme protein and use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4720454A (en) * 1984-04-18 1988-01-19 White Perrin C Genetic probe used in the detection of adrenal hyperplasia

Also Published As

Publication number Publication date
KR900702022A (en) 1990-12-05
PT90484B (en) 1994-08-31
DK264890A (en) 1990-11-05
DE68929296T2 (en) 2001-12-06
FI905464A0 (en) 1990-11-05
JPH04500303A (en) 1992-01-23
WO1989010963A1 (en) 1989-11-16
ATE201235T1 (en) 2001-06-15
AU3575989A (en) 1989-11-29
NZ229032A (en) 1992-06-25
KR100256025B1 (en) 2000-05-01
JPH11308991A (en) 1999-11-09
PT90484A (en) 1989-11-30
NO904791L (en) 1991-01-04
HUT54413A (en) 1991-02-28
NO904791D0 (en) 1990-11-05
HU217411B (en) 2000-01-28
JP2963711B2 (en) 1999-10-18
IL90207A (en) 1994-07-31
HU893289D0 (en) 1990-12-28
CA1340616C (en) 1999-06-29
AU635494B2 (en) 1993-03-25
NO314267B1 (en) 2003-02-24
CN1038667A (en) 1990-01-10
FI109605B (en) 2002-09-13
IL90207A0 (en) 1989-12-15
DK264890D0 (en) 1990-11-05
DE68929296D1 (en) 2001-06-21
DK175573B1 (en) 2004-12-13

Similar Documents

Publication Publication Date Title
AU641641B2 (en) Process for isolating nucleic acid
ES2157883T3 (en) PROCEDURE FOR THE BIOCHEMICAL OXIDATION OF STEROIDS AND CELLS TRANSFORMED BY GENETIC ENGINEERING FOR THIS PURPOSE.
White et al. A role for the TATA-box-binding protein component of the transcription factor IID complex as a general RNA polymerase III transcription factor.
Yamada et al. Proton motive force-dependent and-independent protein translocation revealed by an efficient in vitro assay system of Escherichia coli
ATE314462T1 (en) METHOD FOR TRANSFORMING DENDRITIC CELLS AND ACTIVATION OF T CELLS
Bonner The template activity of chromatin
Vishniac The activity of steroids as growth factors for a Labyrinthula sp.
Sauer et al. Methane synthesis by membrane vesicles and a cytoplasmic cofactor isolated from Methanobacterium thermoautotrophicum
GB2321702B (en) Methods and means relating to retrotransposon and retroviral integration
WO1999047673A3 (en) Isolated mammalian membrane protein genes and related reagents
EP0194626A3 (en) Method for transformation and direct selection of transformants in eucaryotic cells
Raman Meiotic Cell Division–Why and How?: A Genetic Perspective.
Sridhara et al. Preparation and Properties of Chromatin from the Silk Glands of the Silkworm Bombyx mori
NO902261L (en) PROCEDURE FOR MULTIPLE OXIDATION OF STEROIDS AND GENETICALLY CONSTRUCTED CELLS FOR SUCH USE.
WO2026035693A3 (en) Methods for building artificial rna organelles in living cells
ATE107363T1 (en) PREPARATION OF 7-BETA-HYDROXY-4-PREGNEN-3,20-DIONE DERIVATIVES.
Wiseman NUCLEAR RNA POLYMERASE ACTIVITY IN THE RAT INTESTINAL EPITHELIUM: A COMPARISON OF UNDIFFERENTIATED CRYPT CELLS AND DIFFERENTIATED VILLUS EPITHELIAL CELLS.
Wileman Endocytosis
Sullivan et al. Effects of prednisolone and butyrate on agglutinability of HeLa cells by concanavalin A
Chandler NONSPECIFIC AND SPECIFIC INTERACTIONS OF RNA POLYMERASES WITH SV40 DNA.
Levinson Identification of cellular factors required for intracellular receptor signaling and transcriptional activation

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 340878

Country of ref document: ES